Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Trial details
- Registry ID
- NCT07209462
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)NCT07209462 | MIRM | Phase 2 | Recruiting | 2027-10Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |